Sec. 1. Short title; table of contents
412 words·~2 min read·
/bill/118/hr/4697/ih/section-1·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
This Act may be cited as the or the Protecting Pandemic and All-Hazards Preparedness Act of 2023 . Protecting PAHPA Act of 2023 The table of contents for this Act is as follows: Sec. 1. Short title; table of contents. Title I—Preparing for and responding to public health security threats Sec. 101. National health security strategy. Sec. 102. Protection of national security from threats. Sec. 103. Partnerships for State and regional hospital preparedness to improve surge capacity.
Sec. 104. Guidelines for regional health care emergency preparedness and response systems. Sec. 105. Strategic National Stockpile. Sec. 106. Diagnostic testing preparedness plan. Sec. 107. Biomedical Advanced Research and Development Authority. Sec. 108. Ensuring collaboration and coordination in medical countermeasure development. Sec. 109. Review of ASPR efforts to ensure supply chain resiliency and accountability. Sec. 110. Review of HHS efforts To ensure rapid production and domestic manufacturing capacity of medical countermeasures.
Sec. 111. Crisis standards of care. Title II—Ensuring workforce to prepare for and respond to public health security threats Sec. 201. Emergency system for advance registration of volunteer health professional. Sec. 202. Military and civilian partnership for trauma readiness. Sec. 203. National advisory committees on disasters. Sec. 204. National Disaster Medical System. Sec. 205. Volunteer Medical Reserve Corps. Title III—Preparing for and responding to public health security threats Sec. 301.
Improving State and local public health security. Sec. 302. Facilities and capacities of the Centers for Disease Control and Prevention to combat public health security threats. Sec. 303. Monitoring and distribution of certain medical countermeasures. Sec. 304. Enhanced control of dangerous biological agents and toxins. Sec. 305. Mosquito-borne diseases. Sec. 306. Epidemiology-laboratory capacity. Sec. 307. Supporting public health data availability and access. Title IV—Ensuring workforce to prepare for and respond to public health security threats Sec. 401.
Temporary reassignment of State and local personnel during a public health emergency. Sec. 402. Epidemic Intelligence Service. Title V—Addressing drug and supply chain shortages Subtitle A—Ensuring access to lifesaving drugs Sec. 501. Extended expiration dates for life-saving drugs. Subtitle B—Drug origin transparency Sec. 511. Enhanced drug manufacturing amount information reporting. Sec. 512. Require drug labeling to include original manufacturer and supply chain information.
Subtitle C—Medical device shortage reduction Sec. 521. Clarifying device shortage notifications. Sec. 522. Supply chain risk management. Sec. 523. Clarifying voluntary notifications. Subtitle D—Drug shortage prevention Sec. 531. Improving notification procedures in case of increased demand for critical essential medicines. Subtitle E—Protecting Americans from unsafe drugs Sec. 541. Notification, nondistribution, and recall of drugs.